3

OWNERSHIP DOCUMENT

Company: BRAINSTORM CELL THERAPEUTICS INC.
Filed: November 20, 2017
Period of Report: November 20, 2017
Accession Number: 0001144204-17-060146

View Document ↗ View on SEC.gov ↗